Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor
Keith Biggadike, Randy K. Bledsoe, Dan Coe et al. · Proceedings of the National Academy of Sciences · 2009
Crystallography and computer modeling have been used to exploit a previously unexplored channel in the glucocorticoid receptor (GR). Highly potent, nonsteroidal indazole amides showing excellent complementarity to the channel were designed with the assistance of the computational technique AlleGrow. The accuracy of the design process was demonstrated through crystallographic structural determination of the GR ligand-binding domain-agonist complex of the D-prolinamide derivative 11. The utility of the channel was further exemplified through the design of a potent phenylindazole in which structural motifs, seen to interact with the traditional GR ligand pocket, were abandoned and replaced by interactions within the new channel. Occupation of the channel was confirmed with a second GR crystal structure of this truncated D-alaninamide derivative 13. Compound 11 displays properties compatible with development as an intranasal solution formulation, whereas oral bioavailability has been demonstrated with a related truncated exemplar 14. Data with the pyrrolidinone amide 12 demonstrate the potential for further elaboration within the "meta" channel to deliver compounds with selectivity for the desired transrepressive activity of glucocorticoids. The discovery of these interactions with this important receptor offers significant opportunities for the design of novel GR modulators.
Cited by 71 works. doi:10.1073/pnas.0909125106
Authors
- Keith Biggadike
- Randy K. Bledsoe
- Dan Coe
- Tony W. J. Cooper
- David House
- Marie A. Iannone
- Simon J. F. Macdonald
- Kevin P. Madauss
- Iain M. McLay
- Tracy J. Shipley
- Thuy B. Tran
- Iain Uings
- Victoria Weller
- Shawn P. Williams
References
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
- Mechanisms involved in the side effects of glucocorticoids
- Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition
- Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects
- Nuclear receptor cofactors as chromatin remodelers
- Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease
- Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor?
- A fully dissociated compound of plant origin for inflammatory gene repression
- X-ray Crystal Structure of the Novel Enhanced-Affinity Glucocorticoid Agonist Fluticasone Furoate in the Glucocorticoid Receptor−Ligand Binding Domain